文献速递神经肿瘤神经重症

磁共振成像引导激光间质热疗治疗脑放射性坏死的安全性

The safety of magnetic resonance imaging-guided laser interstitial thermal therapy for cerebral radiation necrosis.
PubMed 文献 · J Neurooncol · 2018-03-13

本研究前瞻性收集并回顾性分析2013年11月至2016年1月在亨利福特医院因肿瘤接受激光间质热疗且活检确诊脑放射性坏死的患者,共10例11次消融。平均消融86%的脑放射性坏死体积,消融体积在1-2周增至初始的430%,6个月后降至69%。6个月生存率77.8%,1年生存率64.8%,作者认为激光间质热疗对脑放射性坏死相对安全。

要点

  • 10例患者11次消融,平均消融86%的脑放射性坏死体积。
  • 消融体积1-2周增至初始430%,6个月后降至69%。
  • 6个月生存率77.8%,1年生存率64.8%。

核心结论

  • 作者认为激光间质热疗对脑放射性坏死是相对安全的治疗,为难治性患者提供诊断和治疗方案。
  • 消融体积在1-2个月显著增加,随后逐渐缩小,至6个月时小于原始体积。
  • 需要进一步研究以更好地明确激光间质热疗在脑放射性坏死治疗中的作用。

研究设计与样本

  • 前瞻性收集并回顾性分析2013年11月至2016年1月在亨利福特医院因肿瘤接受激光间质热疗且活检确诊脑放射性坏死的患者。
  • 共评估10例患者11次消融,其中4例原发诊断为高级别胶质瘤,6例为转移性病灶。
  • 影像学检查从消融前开始按设定间隔进行。

主要发现

  • 平均消融86%的脑放射性坏死体积。
  • 消融体积在1-2周增至初始脑放射性坏死体积的430%,6个月后降至69%。
  • 住院期间无患者基线神经系统检查下降。
  • 4例患者出现迟发性神经功能缺损,可能由术后水肿导致,其中3例恢复至基线。
  • 基于Kaplan-Meier曲线估计,6个月生存率为77.8%,1年生存率为64.8%。

局限性

  • 需要进一步研究以更好地明确激光间质热疗在脑放射性坏死治疗中的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cerebral radiation necrosis (CRN) is a known complication of radiation therapy. Treatment options are limited and include steroids, bevacizumab, and surgery. This study seeks to determine the safety of laser interstitial thermal therapy (LITT) for CRN and identify the pattern of post-ablation volume change over time. Patients undergoing LITT for tumor treatment at Henry Ford Hospital between November 2013 and January 2016 with biopsy-confirmed CRN were prospectively collected and retrospectively reviewed with attention to ablation volume, survival, demographic data, steroid dose, and complications. Imaging occurred at set intervals beginning pre-ablation. Ten patients with 11 ablations were evaluated. Four patients had a primary diagnosis of high-grade glioma, while six had metastatic lesions. An average of 86% of CRN volume was ablated. Ablation volume increased to 430% of initial CRN volume at 1-2 weeks before decreasing to 69% after 6 months. No patient had a decline in baseline neurological examination while in the hospital. Four patients developed delayed neurological deficits likely due to post-operative edema, of which three improved back to baseline. The 6-month survival was 77.8% and the 1-year survival was 64.8% based on Kaplan-Meier curve estimates. In this study, LITT was a relatively safe treatment for CRN, providing both a diagnostic and therapeutic solution for refractory patients. Significant increase in ablation volume was noted at 1-2 months, gradually decreasing in size to less than the original volume by 6 months. Further studies are needed to better define the role of LITT in the treatment of CRN.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Rammo R, Asmaro K, Schultz L, et al. The safety of magnetic resonance imaging-guided laser interstitial thermal therapy for cerebral radiation necrosis. J Neurooncol. 2018. PMID: 29536345. doi:10.1007/s11060-018-2828-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。